Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
Jump to:
Preferred Name | tocilizumab | |
Synonyms |
|
|
ID |
http://purl.obolibrary.org/obo/dinto_DB06273 |
|
AHFScode |
92:36
|
|
ATCCode |
L04AC07
|
|
binds | ||
CASRN |
375823-41-9
|
|
DBBrand |
actemra
|
|
DBSynonym |
atlizumab mra roactemra? r-1569
|
|
Definition |
Tocilizumab is a recombinant, humanized, anti-human interleukin 6 (IL-6) receptor monoclonal antibody that achieves a significant therapeutic response rate. The light chain is made up of 214 amino acids. The heavy chain is made up of 448 amino acids. The four polypeptide chains are linked intra- and inter-molecularly by disulfide bonds. FDA approved on January 8, 2010.
|
|
has pharmacological target | ||
label |
tocilizumab
|
|
may interact with |
http://purl.obolibrary.org/obo/CHEBI_9150 http://purl.obolibrary.org/obo/dinto_DB06674 http://purl.obolibrary.org/obo/dinto_DB00514 |
|
prefixIRI |
obo2:dinto_DB06273
|
|
prefLabel |
tocilizumab
|
|
related with | ||
xref |
National Drug Code Directory:50242-137-01 Drugs.com:http://www.drugs.com/international/tocilizumab.html RxList:http://www.rxlist.com/actemra-drug.htm PharmGKB:PA165292659 Wikipedia:http://en.wikipedia.org/wiki/Tocilizumab
|
|
subClassOf |
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping